Choksi Laboratories Complete Financial Statements
In FY2026, Choksi Laboratories (CHOKSILA) reported revenue ₹46 Cr, net profit ₹2 Cr and EPS ₹2.82, with a net profit margin of 4.3% and ROE of 7.7%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see CHOKSILA share price.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CHOKSILA Revenue, Net Profit & EBITDA — Year-on-Year Growth
CHOKSILA YoY (March 2025 vs March 2026) — revenue +9.5%, EBITDA +9.1%, expenses +9.7%. Also explore CHOKSILA price movement history to track price trends across different timeframes.
CHOKSILA Income Statement — Revenue, EBITDA & Net Profit
Choksi Laboratories revenue ₹46 Cr, EBITDA ₹12 Cr, net profit ₹2 Cr, EPS ₹2.82 (2026) — net profit margin 4.3%. Analyse CHOKSILA promoter holding to track promoter, FII and institutional holdings.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 42 | 37 | 35 | 30 | 26 | 29 | 34 | 31 | 30 | 22 | 23 |
| Expenses | 34 | 31 | 27 | 24 | 21 | 22 | 25 | 27 | 24 | 24 | 17 | 17 |
| EBITDA | 12 | 11 | 10 | 11 | 9 | 5 | 3 | 8 | 7 | 6 | 5 | 6 |
| Operating Profit Margin % | 26.00% | 27.00% | 28.00% | 30.00% | 30.00% | 16.00% | 10.00% | 22.00% | 21.00% | 17.00% | 23.00% | 23.00% |
| Depreciation | 7 | 7 | 6 | 6 | 5 | 5 | 5 | 4 | 3 | 3 | 3 | 3 |
| Interest | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 |
| Profit Before Tax | 3 | 2 | 2 | 4 | 0 | -3 | -6 | 2 | 2 | 1 | 1 | 1 |
| Tax | 1 | 1 | 1 | 1 | 0 | 0 | -2 | 1 | 1 | 0 | 0 | 1 |
| Net Profit | 2 | 2 | 1 | 3 | 0 | -3 | -4 | 2 | 1 | 1 | 1 | 1 |
| Earnings Per Share (₹) | 2.82 | 2.19 | 1.59 | 4.61 | 0.30 | -3.74 | -5.58 | 2.30 | 1.93 | 1.28 | 1.04 | 1.27 |
CHOKSILA Balance Sheet — Assets, Liabilities & Shareholders' Equity
CHOKSILA total assets ₹72 Cr, total equity ₹26 Cr, total liabilities ₹ Cr (2026) — ROE 7.7%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 72 | 65 | 62 | 60 | 64 | 66 | 65 | 55 | 45 | 41 | 43 | 38 |
| Current Assets | 19 | 16 | 15 | 14 | 14 | 13 | 17 | 16 | 15 | 13 | 15 | 15 |
| Fixed Assets | 52 | 48 | 43 | 45 | 47 | 50 | 33 | 35 | 29 | 22 | 18 | 19 |
| Capital Work in Progress | 0 | 0 | 3 | 0 | 2 | 1 | 13 | 3 | 0 | 4 | 9 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 18 | 16 | 15 | 16 | 16 | 19 | 17 | 16 | 14 | 16 | 16 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 23 | 18 | 21 | 27 | 31 | 32 | 30 | 18 | 7 | 5 | 9 | 7 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 26 | 24 | 22 | 21 | 18 | 18 | 20 | 24 | 22 | 21 | 20 | 19 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 19 | 17 | 15 | 14 | 11 | 11 | 13 | 17 | 15 | 14 | 13 | 12 |
CHOKSILA Cash Flow Statement — Operating, Investing & Financing
Choksi Laboratories operating cash flow ₹12 Cr, investing ₹-8 Cr, financing ₹-4 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | 12 | 8 | 8 | 6 | 3 | 7 | 6 | 7 | 0 | 2 |
| Investing Activities | -8 | -7 | -1 | -3 | -8 | -14 | -10 | -5 | -2 | 0 | -1 |
| Financing Activities | -4 | -5 | -8 | -5 | 2 | 11 | 2 | -1 | -5 | 0 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |